Laddar...
How we will treat chronic myeloid leukemia in 2016
Imatinib will become generic in 2016; assuming that its price will decrease precipitously, we expect that the economic forces will change our current practice habits. We reviewed the literature on the current recommendations to treat chronic myeloid leukemia and highlight how we plan to deal with th...
Sparad:
| I publikationen: | Blood Rev |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2014
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4385463/ https://ncbi.nlm.nih.gov/pubmed/25555325 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.blre.2014.12.003 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|